Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: A tract-based spatial statistics study

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Worker, Amanda ^a,b   Blain, Camilla ^a,c   Jarosz, Jozef ^c   Chaudhuri, K Ray ^a,b,c   Barker, Gareth J ^a   Williams, Steve C R ^a,b   Brown, Richard G ^a,b   Leigh, P Nigel ^d   Dell'acqua, Flavio ^a,b   Simmons, Andrew ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTERIOR THALAMIC RADIATION; ARTICLE; CAPSULA INTERNA; CENTRAL NERVOUS SYSTEM; CEREBRAL PEDUNCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONA RADIATA (BRAIN); CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; EXTERNAL CAPSULE; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; INTERMETHOD COMPARISON; MALE; MEAN DIFFUSIVITY; MEDIAL LEMNISCUS; NERVE DEGENERATION; PARKINSON DISEASE; PHYSICAL PARAMETERS; PROGRESSIVE SUPRANUCLEAR PALSY; PYRAMIDAL TRACT; SHY DRAGER SYNDROME; SUPERIOR CEREBELLAR PEDUNCLE; SUPERIOR LONGITUDINAL FASCICULUS; BRAIN; CASE CONTROL STUDY; COMPUTER ASSISTED DIAGNOSIS; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PATHOLOGY; SUPRANUCLEAR PALSY, PROGRESSIVE;

ADULT; BRAIN; CASE-CONTROL STUDIES; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84913541633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112638     Document Type: Article

References (48)

1. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, et al. (2003) SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Movement Disorders 18: 467-486.
2. Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, et al. (2009) Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS study. Brain 132: 156-171.
3. Braak H, Braak E (2000) Pathoanatomy of Parkinson's disease. Journal of Neurology 247: II3-II10.
4. Braak H, Tredici KD, Rüb U, de Vos RA, Jansen Steur EN, et al. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of aging 24: 197-211.
5. Hauw J-J, Daniel S, Dickson D, Horoupian D, Jellinger K, et al. (1994) Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44: 2015-2015.
6. Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, et al. (2006) Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Archives of neurology 63: 81-86.
7. Price S, Paviour D, Scahill R, Stevens J, Rossor M, et al. (2004) Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 23: 663-669.
8. Schocke M, Seppi K, Esterhammer R, Kremser C, Jaschke W, et al. (2002) Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 58: 575-580.
9. Prodoehl J, Li H, Planetta PJ, Goetz CG, Shannon KM, et al. (2013) Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Movement Disorders 28: 1816-1822.
10. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junqué C, et al. (2012) Assessment of cortical degeneration in patients with Parkinson's disease by voxelbased morphometry, cortical folding, and cortical thickness. Human brain mapping 33: 2521-2534.
11. Basser PJ, Mattiello J, LeBihan D (1994) MR diffusion tensor spectroscopy and imaging. Biophysical journal 66: 259-267.
12. Padovani A, Borroni B, Brambati SM, Agosti C, Broli M, et al. (2006) Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. Journal of Neurology, Neurosurgery & Psychiatry 77: 457- 463.
13. Caso F, Agosta F, Volontè MA, Martinelli D, Sarro L, et al. (2014) Mapping Regional Grey and White Matter Damage in Patients with Progressive Supranuclear Palsy Syndrome (S57. 007). Neurology 82: S57. 007-S057. 007.
14. Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, et al. (2011) Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Archives of neurology 68: 753-760.
15. Tsuboi Y, Slowinski J, Josephs KA, Honer WG, Wszolek ZK, et al. (2003) Atrophy of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 60: 1766-1769.
16. Agosta F, Pievani M, Svetel M, Ječmenica Lukić M, Copetti M, et al. (2012) Diffusion tensor MRI contributes to differentiate Richardson's syndrome from PSP-parkinsonism. Neurobiology of aging 33: 2817-2826.
17. Agosta F, Galantucci S, Svetel M, Lukić MJ, Copetti M, et al. (2014) Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy. Journal of neurology 261: 913-924.
18. Paviour DC, Thornton JS, Lees AJ, Jäger HR (2007) Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiplesystem atrophy from progressive supranuclear palsy. Movement disorders 22: 68-74.
19. Blain C, Barker G, Jarosz J, Coyle N, Landau S, et al. (2006) Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 67: 2199-2205.
20. Hattori T, Orimo S, Aoki S, Ito K, Abe O, et al. (2012) Cognitive status correlates with white matter alteration in Parkinson's disease. Human brain mapping 33: 727-739.
21. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, et al. (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
22. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, et al. (1999) Consensus statement on the diagnosis of multiple system atrophy. Journal of the neurological sciences 163: 94-98.
23. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson's disease A clinicopathologic study. Neurology 42: 1142-1142.
24. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson- Olszewski syndrome) Report of the NINDS-SPSP International Workshop∗. Neurology 47: 1-9.
25. Hoehn MM, Yahr MD (1998) Parkinsonism: onset, progression, and mortality. Neurology 50: 318-318.
26. Schwab RS, England AC (1969) Projection technique for evaluating surgery in Parkinson's disease; pp. 152-157.
27. Fahn S, Elton RL, Committee UD (1987) Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 2: 153-163.
28. Payan C, Vidailhet M, Lacomblez L, Viallet F, Borg M, et al. Neuroprotection and natural history in Parkinson plus syndromes (NNIPPS): construction and validation of a functional scale for disease progression assessment in Parkinson plus syndromes, progressive supranuclear palsy (PSP) and multiple system atrophy (MSA); 2002. WILEY-LISS DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA. pp. S256-S256.
29. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research 12: 189-198.
30. Mattis S (1988) Dementia rating scale. Odessa, FL: Psychological Assessment Resources.
31. Simmons A, Moore E, Williams SC (1999) Quality control for functional magnetic resonance imaging using automated data analysis and Shewhart charting. Magnetic Resonance in Medicine 41: 1274-1278.
32. Leemans A, Jeurissen B, Sijbers J, Jones D (2009) Explore DTI: A graphical toolbox for processing, analyzing, and visualizing diffusion MR data; pp. 3537.
33. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, et al. (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23: S208-S219.
34. Smith SM (2002) Fast robust automated brain extraction. Human brain mapping 17: 143-155.
35. Hua K, Zhang J, Wakana S, Jiang H, Li X, et al. (2008) Tract probability maps in stereotaxic spaces: Analyses of white matter anatomy and tract-specific quantification. Neuroimage 39: 336-347.
36. Knake S, Belke M, Menzler K, Pilatus U, Eggert KM, et al. (2010) In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: A DTI study using TBSS. Movement Disorders 25: 1232-1238.
37. Seppi K, Schocke MF, Prennschuetz-Schuetzenau K, Mair KJ, Esterhammer R, et al. (2006) Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study. Movement disorders 21: 847-852.
38. Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, et al. (2008) Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 131: 2690-2700.
39. Tsukamoto K, Matsusue E, Kanasaki Y, Kakite S, Fujii S, et al. (2012) Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology 54: 947- 955.
40. Pierpaoli C, Barnett A, Pajevic S, Chen R, Penix L, et al. (2001) Water diffusion changes in Wallerian degeneration and their dependence on white matter architecture. Neuroimage 13: 1174-1185.
41. Ito S, Makino T, Shirai W, Hattori T (2008) Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy. Neuroradiology 50: 981-985.
42. Josephs KA, Xia R, Mandrekar J, Gunter JL, Senjem ML, et al. (2013) Modeling trajectories of regional volume loss in progressive supranuclear palsy. Movement Disorders 28: 1117-1124.
43. Brenneis C, Seppi K, Schocke M, Benke T, Wenning G, et al. (2004) Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. Journal of Neurology, Neurosurgery & Psychiatry 75: 246- 249.
44. Ishizawa K, Dickson DW (2001) Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration. Journal of Neuropathology & Experimental Neurology 60: 647-657.
45. Kreutzberg GW (1996) Microglia: A sensor for pathological events in the CNS. Trends in neurosciences 19: 312-318.
46. Klegeris A MP (1997) Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 49: 229-235.
47. Ishizawa K, Komori T, Sasaki S, Arai N, Mizutani T, et al. (2004) Microglial activation parallels system degeneration in multiple system atrophy. Journal of Neuropathology & Experimental Neurology 63: 43-52.
48. Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, et al. (2007) Microglial activation mediates neurodegeneration related to oligodendroglial asynucleinopathy: Implications for multiple system atrophy. Movement Disorders 22: 2196-2203.